Theranos made a big splash in Arizona in 2015 when Gov. Doug Ducey welcomed the company with open arms. At that stage, it was seen as an innovator in the realm of medical testing and equipment — including a portable blood analyzer that only needed a simple finger prick.
That, its CEO Elizabeth Holmes claimed, would be the faster and less expensive option to more conventional lab testing. Investors had already jumped in to the tune of several hundred million dollars. Unfortunately, Holmes’ claims weren’t accurate.
John Carreyrou, Wall Street Journal reporter, was the one who broke the story and now he’s written a book called "Bad Blood: Secrets and Lies in a Silicon Valley Startup," and he joined The Show to talk about it.
